ArticleCureus2026
Reversible HIV-Associated Nephropathy and Concomitant Encephalomyelopathy as the Initial Presentation of Advanced, Untreated HIV.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human immunodeficiency virus (HIV) can cause severe multiorgan dysfunction when left untreated. Concurrent, severe renal and central nervous system manifestations as the primary presentation of advanced HIV are rare in modern clinical practice. We report a case of a young female presenting with dialysis-dependent acute kidney injury (AKI) from HIV-associated nephropathy (HIVAN) and paraplegia from HIV encephalomyelopathy, both of which demonstrated remarkable recovery following antiretroviral therapy (ART). A 31-year-old female presented with a 1-week history of pyrexia, malaise, and rapidly progressive bilateral lower limb weakness. She is a PLHIV (people living with HIV) and was diagnosed seven years ago; she had defaulted from follow-up before starting ART. Laboratory investigations revealed stage 3 AKI, with serum creatinine rising from 403 umol/L on admission to 1112 umol/L within two weeks, alongside high-grade proteinuria. Serology confirmed a plasma HIV-1 RNA viral load of 3,440,753 copies/mL and a CD4 T-cell count below the limit of detection (<8 cells/uL). A renal biopsy demonstrated classic histopathological features of HIVAN, showing collapsing glomerulopathy. Magnetic resonance imaging (MRI) of the brain and spine demonstrated extensive, diffuse abnormal T2-weighted fluid-attenuated inversion recovery (T2/FLAIR) signal intensities involving the cerebral hemispheres, basal ganglia, brainstem, and a long segment of the cervical cord, consistent with an advanced neuro-axis injury. Cerebrospinal fluid (CSF) analysis and CSF culture ruled out opportunistic neuro-infections. The patient was initiated on regular haemodialysis and an intensive antiretroviral regimen consisting of dolutegravir/lamivudine, darunavir, and ritonavir, alongside co-trimoxazole prophylaxis until her CD4 count was over 200 cells/mm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.